- Home
- NRSN vs JSPR Comparison
NRSN vs JSPR Comparison
Compare NRSN & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- JSPR
- Stock Information
- Founded
- NRSN 2017
- JSPR 2018
- Country
- NRSN Israel
- JSPR United States
- Employees
- NRSN N/A
- JSPR N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NRSN Health Care
- JSPR Health Care
- Exchange
- NRSN Nasdaq
- JSPR Nasdaq
- Market Cap
- NRSN 50.1M
- JSPR 47.6M
- IPO Year
- NRSN 2021
- JSPR N/A
- Fundamental
- Price
- NRSN $1.06
- JSPR $2.80
- Analyst Decision
- NRSN Buy
- JSPR Buy
- Analyst Count
- NRSN 2
- JSPR 12
- Target Price
- NRSN $14.00
- JSPR $30.78
- AVG Volume (30 Days)
- NRSN 353.2K
- JSPR 215.8K
- Earning Date
- NRSN 09-29-2025
- JSPR 08-13-2025
- Dividend Yield
- NRSN N/A
- JSPR N/A
- EPS Growth
- NRSN N/A
- JSPR N/A
- EPS
- NRSN N/A
- JSPR N/A
- Revenue
- NRSN N/A
- JSPR N/A
- Revenue This Year
- NRSN N/A
- JSPR N/A
- Revenue Next Year
- NRSN N/A
- JSPR N/A
- P/E Ratio
- NRSN N/A
- JSPR N/A
- Revenue Growth
- NRSN N/A
- JSPR N/A
- 52 Week Low
- NRSN $0.68
- JSPR $2.27
- 52 Week High
- NRSN $2.60
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- NRSN 33.59
- JSPR 39.48
- Support Level
- NRSN $1.05
- JSPR $2.91
- Resistance Level
- NRSN $1.17
- JSPR $3.05
- Average True Range (ATR)
- NRSN 0.12
- JSPR 0.16
- MACD
- NRSN 0.01
- JSPR 0.05
- Stochastic Oscillator
- NRSN 10.00
- JSPR 37.04
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.